Observational studyThe Korean journal of internal medicine2017
Impact of early diagnosis on functional disability in rheumatoid arthritis.
Observational study in The Korean journal of internal medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 17 citations in OpenAlex.
- Treat-to-Target Strategy for Asian Patients with Early Rheumatoid Arthritis: Result of a Multicenter Trial in Korea.Journal of Korean medical science · 2018Trial
- Synovial microenvironment and fluorescence imaging for early rheumatoid arthritis diagnosis.Journal of pharmaceutical analysis · 2026Review
- Design of a Self-Measuring Device Based on Bioelectrical Impedance Analysis for Regular Monitoring of Rheumatoid Arthritis.Sensors (Basel, Switzerland) · 2024Article
- Factors Leading to Diagnostic and Therapeutic Delay of Rheumatoid Arthritis and Their Impact on Disease Outcome.Cureus · 2023Article
- Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic.Clinical rheumatology · 2022Review
- A paradigm shift in studies based on rheumatoid arthritis clinical registries.The Korean journal of internal medicine · 2019Review
- Factors associated with time to diagnosis from symptom onset in patients with early rheumatoid arthritis.The Korean journal of internal medicine · 2019Observational
- Trends in Prevalence of Functional Disability in Rheumatoid Arthritis Compared With the General Population.Mayo Clinic proceedings · 2019Article
- Impact of early diagnosis on functional preservation in patients with rheumatoid arthritis: the early bird catches the worm.The Korean journal of internal medicine · 2017Article
- Diagnostic and therapeutic delay in Rheumatoid Arthritis patients: Impact on disease outcome.Pakistan journal of medical sciencesArticle
Corrections and comments
- Commented on by
Authors and funding
29 authors at 14 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimsTo determine whether early diagnosis is beneficial for functional status of various disease durations in rheumatoid arthritis (RA) patients.
methodsA total of 4,540 RA patients were enrolled as part of the Korean Observational Study Network for Arthritis (KORONA). We defined early diagnosis as a lag time between symptom onset and RA diagnosis of ≤ 12 months, whereas patients with a longer lag time comprised the delayed diagnosis group. Demographic characteristics and outcomes were compared between early and delayed diagnosis groups. Logistic regression analyses were performed to identify the impact of early diagnosis on the development of functional disability in RA patients.
resultsA total of 2,597 patients (57.2%) were included in the early diagnosis group. The average Health Assessment Questionnaire-Disability Index (HAQ-DI) score was higher in the delayed diagnosis group (0.64 ± 0.63 vs. 0.70 ± 0.66,
conclusionsEarly diagnosis is associated with no functional disability, especially in patients with shorter disease duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.